2nd Balkan and Eastern European Masterclass in Clinical Oncology
30 ESCO credits
09.05.2012 - 13.05.2012
Dubrovnik
MASTERCLASS
Description
Chair: R. Popescu, CH/RO
Co-Chair: S. Beslija, BA
AIMS AND OBJECTIVES
This clinically oriented residential educational programme has been designed for dedicated physicians wishing to improve their skills in the management of cancer patients. The 2nd ESO Balkan Masterclass is dedicated to clinicians who are specifically and almost exclusively dedicated to medical oncology, radiation oncology and surgical oncology (breast and colon). The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on lung, GI and breast cancers.
TEACHING FORMAT
The Masteclass offers plenary lectures regarding the state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which conclude in taking-home messages. Furthermore, practical training will be offered in the frame of clinical case presentations prepared and presented by the faculty and participants for an interactive discussion.
All participants will reside at the masterclass venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
THE MASTERCLASS IS
• A 3-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of experts delivering lectures focusing on lung, GI and breast cancers
General information
ORGANISING SECRETARIAT
Daniela Mengato - Roberta Ventura
European School of Oncology (ESO)
Via del Bollo, 4
20123 Milan, Italy
Tel: +39 02 8546 4523 or +39 02 85464532
Fax: +39 02 8546 4545
Email: balkans@eso.net
VENUE
Radisson Blu Resort & SPA
Dubrovnik Sun Gardens
Na Moru 1
Orašac Dubrovnik, Croatia
Tel: +385 20 361 500
Fax: +385 20 361 501
www.radissonblu.com/resort-dubrovnik
CME ACCREDITATION AND CERTIFICATES
The masterclass has been appraised and approved by the Accreditation Council of Oncology in Europe (ACOE) acknowledging the quality of the scientific programme and its educational value.
ACOE is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The “2nd Balkan and Eastern European Masterclass in Clinical Oncology” is designated for a maximum of 19 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The programme is furthermore accredited with 25 ESMO-MORA cat. 1 points.
Daniela Mengato - Roberta Ventura
European School of Oncology (ESO)
Via del Bollo, 4
20123 Milan, Italy
Tel: +39 02 8546 4523 or +39 02 85464532
Fax: +39 02 8546 4545
Email: balkans@eso.net
VENUE
Radisson Blu Resort & SPA
Dubrovnik Sun Gardens
Na Moru 1
Orašac Dubrovnik, Croatia
Tel: +385 20 361 500
Fax: +385 20 361 501
www.radissonblu.com/resort-dubrovnik
CME ACCREDITATION AND CERTIFICATES
The masterclass has been appraised and approved by the Accreditation Council of Oncology in Europe (ACOE) acknowledging the quality of the scientific programme and its educational value.
ACOE is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The “2nd Balkan and Eastern European Masterclass in Clinical Oncology” is designated for a maximum of 19 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The programme is furthermore accredited with 25 ESMO-MORA cat. 1 points.
Faculty list
FACULTY
S. Beslija, Institute of Oncology, Clinical Center Sarajevo University, Sarajevo, BA
G. Cserni, Bacs Miskun County Teaching Hospital, Kecskemet, HU
T. Cufer, University Clinic of Respiratory and Allergic Diseases, Golnik, SI
A. Eniu, Cancer Institute "I. Chiricuta", Cluj-Napoca, RO
V. Gregorc, San Raffaele Scientific Institute, Milano, IT
D. Jovanovic, Institute for Lung Disease, Clinical Center of Serbia, Belgrade, RS
I. Kern, University Clinic of Pulmonary and Allergic Disease, Golnik, SI
R. Labianca, Ospedali Riuniti di Bergamo, IT
D. Mosoiu, Hospice Casa Sperantei, Brasov, RO
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
R. Popescu, Hirslanden Klinik Aarau, CH/RO
M. Siano, Cantonal Hospital, St. Gallen, CH (e-ESO online live session)
J. Temel, Massachusetts General Hospital, Boston, US (e-ESO online live session)
E. Vrdoljak, Clinical Hospital Split, Medical School Split, HR
J. Zgajnar, Institute of Oncology, Ljubljana, SI
Programme
9 May
18:30 | Welcome address and general introduction |
20:00 | Dinner |
10 May
LUNG CANCER | |
8:00 | Pathology and molecular biology of lung cancer |
8:35 | Diagnostic procedures, staging and surgery of lung cancer D. Jovanovic, SR |
9:10 | Combined chemo-radiotherapy in lung cancer |
| 9:45 | Coffee break |
10:15 | Adjuvant/neoadjuvant systemic therapy in NSCLC T. Cufer, SI |
10:50 | Systemic therapy for advanced NSCLC V. Gregorc, IT |
11:25 | Systemic therapy for SCLC V. Gregorc, IT |
13:00 | Lunch |
| 15:30-18:00 Case presentations and discussions with interactive voting Panellists: I. Kern, SI - D. Jovanovic, SR - E. Vrdoljak, HR - T. Cufer, SI - V. Gregorc, IT | |
18:15 | e-session on palliative care in lung cancer Expert: Jennifer Temel, Massachusetts General Hospital, Boston, US Discussant: Marco Siano, Cantonal Hospital, St. Gallen, CH |
20:00 | Dinner |
11 May
GI CANCERS | |
8:00 | Pathology of colorectal and gastric cancer |
8:25 | Systemic therapy for advanced colorectal cancer D. Papamichael, CY |
9:25 | Adjuvant chemotherapy for colorectal cancer: key messages R. Popescu, CH/RO |
9:45 | Rectal cancer: chemo-radiotherapy E. Vrdoljak, HR |
10:30 | Coffee break |
11:00 | Multimodal therapy for colorectal cancer with liver metastases R. Labianca, IT |
11:30 | Optimal treatment of elderly patients with colorectal cancer D. Papamichael, CY |
| 12:00 | Gastric Cancer R. Labianca, IT |
| 13:00 | Lunch |
| 16:00-20:00 Case presentations and discussions with interactive voting Panellists: G. Cserni, HU - R. Labianca, IT - D. Papamichael, CY R. Popescu, CH/RO - E. Vrdoljak, HR |
12 May
BREAST CANCER | |
8:00 | Pathology of breast cancer. Epidemiology in the Balkan region G. Cserni, HU |
8:20 | Principles of surgery for breast cancer J. Zgajnar, SI |
8:40 | Principles of Radiotherapy for breast cancer |
| 9:00 | Principles of adjuvant chemotherapy and anti her2 treatment-issues on availability A. Eniu, RO |
9:30 | Principles of adjuvant hormonal therapy for pre-and postmenopausal breast cancer patients |
| 10:00 | Coffee break |
10:30 | Principles of systemic neoadjuvant treatment (chemotherapy, antiHer2, hormonal) for locally advanced disease |
10:50 | Principles of treatment of metastatic disease: hormonal treatment |
| 11:10 | Principles of treatment of metastatic disease: chemotherapy treatment T. Cufer, SI |
| 11:30 | Principles of treatment of metastatic disease: anti-Her2 treatment S. Beslija, BA |
| 13:00 | Lunch |
16:00-20:00 Case presentations and discussions with interactive voting | |
20:00 | Dinner |
13 May
| PALLIATIVE CARE |
8:30 | Palliative care |
9:30 | Discussion and open questions (present faculty) |
10:00 | Closure R. Popescu, CH/RO |